Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nursing Perspective. (25th October 2014)

• Record Type: Journal Article
• Authors: Calvaresi, Anne E.; Trabulsi, Edouard J.; Sonzogni, Maryann; Gomella, Leonard G.; Lallas, Costas D.; Wachsmuth, Kristen S.
• Is Part Of: AORN journal. Volume 100:Number 5(2014.)
• Page Start: 489
• Page End: 499
• Publication Date: 2014-10-25
• Subjects: hexaminolevulinate -- blue light cystoscopy -- bladder cancer -- cystoscopy -- hematuria; Operating room nursing -- Periodicals; Soins infirmiers en salle d'opération -- Périodiques; Nursing -- Periodicals; Operating Room Nursing -- Periodicals; Perioperative Nursing -- Periodicals; Societies, Nursing -- Periodicals; 617.917
• DOI: 10.1016/j.aorn.2013.12.013
• Languages: English
• ISSNs: 0001-2092

Abstract

Abstract: Hexaminolevulinate HCl is a diagnostic imaging agent used with blue light during cystoscopy to help detect non–muscle‐invasive bladder cancer. Blue light cystoscopy performed using hexaminolevulinate HCl has been found to detect more papillary non–muscle‐invasive bladder tumors than cystoscopy performed using standard white light. Because bladder instillation and retention requirements of hexaminolevulinate during cystoscopy can affect patient flow in the perioperative setting, this technique necessitates changes in nursing practice and care of patients with known or suspected non–muscle‐invasive bladder cancer. Nursing personnel at one facility followed the AORN guidelines for preoperative patient care in the ambulatory setting to address staffing, preoperative nursing assessment, anesthesia evaluation, and preoperative teaching related to implementing blue light cystoscopy.